To interrogate further correlations between FOXC1, EZH2 and downstream FOXC1 targets at the protein level in human breast cancer, we made use of recently published proteomic analysis of a subset of TCGA breast cancer patients29. This evidence concerns the gene EZH2 and breast carcinoma.